Lactic acid bacteria to modulate virulence expression in pathogenic bacteria: An alternative to killing?

Interactive Probiotics

Volumn , Issue , 2014, Pages 52-80

  Even, Sergine ^a,b   Bouchard, Damien ^a,b   Loir, Yves Le ^a,b  

^a UMR1253   (France)

^b AGROCAMPUS OUEST   (France)

Author keywords

Adhesion; Aggregation; Bacterial interference; Competition; Gut microbiota; Internalization; Invasiveness; Lactobacilli; Quorum sensing; Toxinogenesis; Vaginal ecosystem; Virulence factors

Indexed keywords

EID: 84944160013     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16439     Document Type: Chapter

References (99)

1. Alemka, A., M. Clyne, F. Shanahan, T. Tompkins, N. Corcionivoschi and B. Bourke. 2010. Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Infect. Immun. 78: 2812-2822.
2. Allaart, J.G., A.J. van Asten, J.C. Vernooij and A. Grone. 2011. Effect of Lactobacillus fermentum on beta2 toxin production by Clostridium perfringens. Appl. Environ. Microbiol. 77: 4406-4411.
3. Archambaud, C., M.A. Nahori, G. Soubigou, C. Becavin, L. Laval, P. Lechat, T. Smokvina, P. Langella, M. Lecuit and P. Cossart. 2012. Impact of lactobacilli on orally acquired listeriosis. Proc. Natl. Acad. Sci. USA 109: 16684-16689.
4. Arroyo, R., V. Martin, A. Maldonado, E. Jimenez, L. Fernandez and J.M. Rodriguez. 2010. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin. Infect. Dis. 50: 1551-1558.
5. Aslam, S., R.J. Hamill and D.M. Musher. 2005. Treatment of Clostridium diffi cile-associated disease: old therapies and new strategies. Lancet Infect. Dis. 5: 549-557.
6. Banerjee, P., G.J. Merkel and A.K. Bhunia. 2009. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium diffi cile to Caco-2 cells. Gut Pathog 1: 8.
7. Beecher, C., M. Daly, D.P. Berry, K. Klostermann, J. Flynn, W. Meaney, C. Hill, T.V. McCarthy, R.P. Ross and L. Giblin. 2009. Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression. J. Dairy Res. 76: 340-348.
8. Bonifait, L., F. Chandad and D. Grenier. 2009. Probiotics for oral health: myth or reality? J. Can. Dent. Assoc. 75: 585-590.
9. Borriello, S.P. 1990. The infl uence of the normal fl ora on Clostridium diffi cile colonisation of the gut. Ann. Med. 22: 61-67.
10. Bouchard, D.S., L. Rault, N. Berkova, Y. Le Loir and S. Even. 2013. Inhibition of Staphylococcus aureus Invasion into Bovine Mammary Epithelial Cells by Contact with Live Lactobacillus casei. Appl. Environ. Microbiol. 79: 877-885.
11. Bouza, E., P. Munoz and R. Alonso. 2005. Clinical manifestations, treatment and control of infections caused by Clostridium diffi cile. Clin Microbiol Infect. 11 Suppl 4: 57-64.
12. Bueschel, D.M., B.H. Jost, S.J. Billington, H.T. Trinh and J.G. Songer. 2003. Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens fi eld isolates: correlation of genotype with phenotype. Vet. Microbiol. 94: 121-129.
13. Bujnakova, D. and V. Kmet. 2012. Inhibitory potential of lactobacilli against Escherichia coli internalization by HT 29 cells. Folia Microbiol. (Praha) 57: 269-272.
14. Campana, R., S. Federici, E. Ciandrini and W. Baffone. 2012. Antagonistic activity of Lactobacillus acidophilus ATCC 4356 on the growth and adhesion/invasion characteristics of human Campylobacter jejuni. Curr. Microbiol. 64: 371-378.
15. Candela, M., F. Perna, P. Carnevali, B. Vitali, R. Ciati, P. Gionchetti, F. Rizzello, M. Campieri and P. Brigidi. 2008. Interaction of probiotic Lactobacillus and Bifi dobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 125: 286-292.
16. Carey, C.M., M. Kostrzynska, S. Ojha and S. Thompson. 2008. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic O157:H7. J. Microbiol. Methods 73: 125-132.
17. Castagliuolo, I., J.T. LaMont, S.T. Nikulasson and C. Pothoulakis. 1996. Saccharomyces boulardii protease inhibits Clostridium diffi cile toxin A effects in the rat ileum. Infect. Immun. 64: 5225-5232.
18. Castagliuolo, I., M.F. Riegler, L. Valenick, J.T. LaMont and C. Pothoulakis. 1999. Saccharomyces boulardii protease inhibits the effects of Clostridium diffi cile toxins A and B in human colonic mucosa. Infect. Immun. 67: 302-307.
19. Castillo, N.A., G. Perdigon and L.A. de Moreno de. 2011. Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC. Microbiol. 11: 177.
20. Collado, M.C., E. Isolauri and S. Salminen. 2008. Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus. FEMS Microbiol. Lett. 285: 58-64.
21. Cossart, P. and A. Toledo-Arana. 2008. Listeria monocytogenes, a unique model in infection biology: an overview. Microbes. Infect. 10: 1041-1050.
22. Cretenet, M., S. Nouaille, J. Thouin, L. Rault, L. Stenz, P. François, J.A. Hennekinne, M. Piot, M.B. Maillard, J. Fauquant, P. Loubière, Y. Le Loir and S. Even. 2011. Staphylococcus aureus virulence and metabolism are dramatically affected by Lactococcus lactis in cheese matrix. Environmental Microbiology Reports 3: 340-351.
23. Crispie, F., M. onso-Gomez, C. O’Loughlin, K. Klostermann, J. Flynn, S. Arkins, W. Meaney, R.R. Paul and C. Hill. 2008. Intramammary infusion of a live culture for treatment of bovine mastitis: effect of live lactococci on the mammary immune response. J. Dairy Res. 75: 374-384.
24. Di Pierro, F., T. Adami, G. Rapacioli, N. Giardini and C. Streitberger. 2013. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert. Opin. Biol. Ther.
25. Di Pierro, F., G. Donato, F. Fomia, T. Adami, D. Careddu, C. Cassandro and R. Albera. 2012. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int. J. Gen. Med. 5: 991-997.
26. Eaton, K.A., A. Honkala, T.A. Auchtung and R.A. Britton. 2011. Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect. Immun. 79: 185-191.
27. Even, S., C. Charlier, S. Nouaille, N. Ben Zakour, M. Cretenet, F.J. Cousin, M. Gautier, M. Cocaign-Bousquet, P. Loubière and Y. Le Loir. 2009. Staphylococcus aureus virulence expression is impaired by Lactococcus lactis in mixed cultures. Appl. Environ. Microbiol. 75: 4459-4472.
28. Fazeli, M.R., M. Hajimohammadali, A. Moshkani, N. Samadi, H. Jamalifar, M.R. Khoshayand, E. Vaghari and S. Pouragahi. 2009. Afl atoxin B1 binding capacity of autochthonous strains of lactic acid bacteria. J. Food Prot. 72: 189-192.
29. Ferreira, C.L., L. Grzeskowiak, M.C. Collado and S. Salminen. 2011. In vitro evaluation of Lactobacillus gasseri strains of infant origin on adhesion and aggregation of specifi c pathogens. J. Food Prot. 74: 1482-1487.
30. Galvez, A., H. Abriouel, R.L. Lopez and O.N. Ben. 2007. Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol. 120: 51-70.
31. Gamage, S.D., C.M. McGannon and A.A. Weiss. 2004. Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2. J. Bacteriol. 186: 5506-5512.
32. Gan, B.S., J. Kim, G. Reid, P. Cadieux and J.C. Howard. 2002. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis. 185: 1369-1372.
33. Gibert, M., C. Jolivet-Reynaud and M.R. Popoff. 1997. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene 203: 65-73.
34. Golowczyc, M.A., P. Mobili, G.L. Garrote, A.G. Abraham and G.L. De Antoni. 2007. Protective action of Lactobacillus kefi r carrying S-layer protein against Salmonella enterica serovar Enteritidis. Int. J. Food Microbiol. 118: 264-273.
35. Gratz, S., M. Taubel, R.O. Juvonen, M. Viluksela, P.C. Turner, H. Mykkanen and H. El-Nezami. 2006. Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of afl atoxin B(1) in rats. Appl. Environ. Microbiol. 72: 7398-7400.
36. Gratz, S., Q.K. Wu, H. El-Nezami, R.O. Juvonen, H. Mykkanen and P.C. Turner. 2007. Lactobacillus rhamnosus strain GG reduces afl atoxin B1 transport, metabolism, and toxicity in Caco-2 Cells. Appl. Environ. Microbiol. 73: 3958-3964.
37. Gueimonde, M., L. Jalonen, F. He, M. Hiramatsu and S. Selminen. 2006. Adhesion and competitive inhibition and displacement of human enteropathogens by selected lactobacilli. Food Research International 39: 467-471.
38. Gyles, C.L. 2007. Shiga toxin-producing Escherichia coli: an overview. J. Anim Sci. 85: E45- E62.
39. Hernandez-Mendoza, A., A.F. Gonzalez-Cordova, B. Vallejo-Cordoba and H.S. Garcia. 2011. Effect of oral supplementation of Lactobacillus reuteri in reduction of intestinal absorption of afl atoxin B(1) in rats. J Basic Microbiol 51: 263-268.
40. Hernandez-Mendoza, A., D. Guzman-de-Pena and H.S. Garcia. 2009. Key role of teichoic acids on afl atoxin B binding by probiotic bacteria. J. Appl. Microbiol. 107: 395-403.
41. Holden, M.T., C.S. Ram, N.R. de, P. Stead, N.J. Bainton, P.J. Hill, M. Manefi eld, N. Kumar, M. Labatte, D. England, S. Rice, M. Givskov, G.P. Salmond, G.S. Stewart, B.W. Bycroft, S. Kjelleberg and P. Williams. 1999. Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria. Mol. Microbiol. 33: 1254-1266.
42. Imamovic, L. and M. Muniesa. 2012. Characterizing RecA-independent induction of Shiga toxin2-encoding phages by EDTA treatment. PLoS. One. 7: e32393.
43. Iwamoto, T., N. Suzuki, K. Tanabe, T. Takeshita and T. Hirofuji. 2010. Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 110: 201-208.
44. Jimenez, E., L. Fernandez, A. Maldonado, R. Martin, M. Olivares, J. Xaus and J.M. Rodriguez. 2008. Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl. Environ. Microbiol. 74: 4650-4655.
45. Jimenez, E., S. Langa, V. Martin, R. Arroyo, R. Martin, L. Fernandez and J.M. Rodriguez. 2010. Complete genome sequence of Lactobacillus fermentum CECT 5716, a probiotic strain isolated from human milk. J. Bacteriol. 192: 4800.
46. Jimenez, E., M.A. Villar-Tajadura, M. Marin, J. Fontecha, T. Requena, R. Arroyo, L. Fernandez and J.M. Rodriguez. 2012. Complete genome sequence of Bifi dobacterium breve CECT 7263, a strain isolated from human milk. J. Bacteriol. 194: 3762-3763.
47. Kakisu, E., A.G. Abraham, F.C. Tironi, C. Ibarra and G.L. De Antoni. 2013. Lactobacillus plantarum isolated from kefi r protects vero cells from cytotoxicity by type-II shiga toxin from Escherichia coli O157:H7. J. Dairy Res. 80: 64-71.
48. Kankainen, M., L. Paulin, S. Tynkkynen, O. von, I.J. Reunanen, P. Partanen, R. Satokari, S. Vesterlund, A.P. Hendrickx, S. Lebeer, S. C. De Keersmaecker, J. Vanderleyden, T. Hamalainen, S. Laukkanen, N. Salovuori, J. Ritari, E. Alatalo, R. Korpela, T. Mattila- Sandholm, A. Lassig, K. Hatakka, K.T. Kinnunen, H. Karjalainen, M. Saxelin, K. Laakso, A. Surakka, A. Palva, T. Salusjarvi, P. Auvinen and W. M. de Vos. 2009. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc. Natl. Acad. Sci. USA 106: 17193-17198.
49. Keller, M.K., A. Bardow, T. Jensdottir, J. Lykkeaa and S. Twetman. 2012. Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour. Acta Odontol. Scand. 70: 246-250.
50. Kim, S.H., S.J. Yang, H.C. Koo, W.K. Bae, J.Y. Kim, J.H. Park, Y.J. Baek and Y.H. Park. 2001. Inhibitory activity of Bifi dobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157:H7. J. Food Prot. 64: 1667-1673.
51. Kim, Y., K.S. Han, J.Y. Imm, S. Oh, S. You, S. Park and S.H. Kim. 2006. Inhibitory effects of Lactobacillus acidophilus lysates on the cytotoxic activity of shiga-like toxin 2 produced from Escherichia coli O157:H7. Lett. Appl. Microbiol. 43: 502-507.
52. Kitov, P.I., J.M. Sadowska, G. Mulvey, G.D. Armstrong, H. Ling, N.S. Pannu, R.J. Read and D.R. Bundle. 2000. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403: 669-672.
53. Kluytmans, J.A. and H.F. Wertheim. 2005. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33: 3-8.
54. Koll-Klais, P., R. Mandar, E. Leibur, H. Marcotte, L. Hammarstrom and M. Mikelsaar. 2005. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol. Immunol. 20: 354-361.
55. Kolling, G.L., M. Wu, C. Alcantara-Warren, E. Durmaz, T.R. Klaenhammer and R.L. Guerrant. 2012. Lactic acid production by Streptococcus thermophilus alters Clostridium diffi cile infection and in vitro Toxin A production. Gut Microbes 3.
56. Koo, O.K., M.A. Amalaradjou and A.K. Bhunia. 2012. Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro. PLoS. One. 7: e29277.
57. Laughton, J.M., E. Devillard, D.E. Heinrichs, G. Reid and J.K. McCormick. 2006. Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology 152: 1155-1167.
58. Le Maréchal, C., R. Thiéry, E. Vautor and Y. Le Loir. 2011. Mastitis impact on technological properties of milk and quality of milk products-a review. Dairy Science and Technologies 91: 247-282.
59. Li, J., W. Wang, S.X. Xu, N.A. Magarvey and J.K. McCormick. 2011. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl. Acad. Sci. USA 108: 3360-3365.
60. Lievin-Le Moal, V., R. Amsellem and A.L. Servin. 2011. Impairment of swimming motility by antidiarrheic Lactobacillus acidophilus strain LB retards internalization of Salmonella enterica serovar Typhimurium within human enterocyte-like cells. Antimicrob. Agents Chemother. 55: 4810-4820.
61. Lin, C.K., H.C. Tsai, P.P. Lin, H.Y. Tsen and C.C. Tsai. 2008. Lactobacillus acidophilus LAP5 able to inhibit the Salmonella choleraesuis invasion to the human Caco-2 epithelial cell. Anaerobe 14: 251-255.
62. Liu, Z., T. Shen, P. Zhang, Y. Ma and H. Qin. 2011. Lactobacillus plantarum surface layer adhesive protein protects intestinal epithelial cells against tight junction injury induced by enteropathogenic Escherichia coli. Mol. Biol. Rep. 38: 3471-3480.
63. Madhwani, T. and A.J. McBain. 2011. Bacteriological effects of a Lactobacillus reuteri probiotic on in vitro oral biofi lms. Arch. Oral Biol. 56: 1264-1273.
64. Martin, V., A. Maldonado-Barragan, E. Jimenez, P. Ruas-Madiedo, L. Fernandez and J.M. Rodriguez. 2012. Complete genome sequence of Streptococcus salivarius PS4, a strain isolated from human milk. J. Bacteriol. 194: 4466-4467.
65. McMillan, A., M. Dell, M.P. Zellar, S. Cribby, S. Martz, E. Hong, J. Fu, A. Abbas, T. Dang, W. Miller and G. Reid. 2011. Disruption of urogenital biofi lms by lactobacilli. Colloids Surf. B Biointerfaces 86: 58-64.
66. Meurman, J.H., H. Antila, A. Korhonen and S. Salminen. 1995. Effect of Lactobacillus rhamnosus strain GG (ATCC 53103) on the growth of Streptococcus sobrinus in vitro. Eur. J. Oral Sci. 103: 253-258.
67. Muniesa, M., J.A. Hammerl, S. Hertwig, B. Appel and H. Brussow. 2012. Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl. Environ. Microbiol. 78: 4065-4073.
68. Musgrave, C.R., P.B. Bookstaver, S.S. Sutton and A.D. Miller. 2011. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium diffi cile infection. Int. J. Infect. Dis. 15: e438-e448.
69. Naaber, P., I. Smidt, J. Stsepetova, T. Brilene, H. Annuk and M. Mikelsaar. 2004. Inhibition of Clostridium diffi cile strains by intestinal Lactobacillus species. J. Med. Microbiol. 53: 551-554.
70. Nakamura, S., T. Kuda, C. An, T. Kanno, H. Takahashi and B. Kimura. 2012. Inhibitory effects of Leuconostoc mesenteroides 1RM3 isolated from narezushi, a fermented fi sh with rice, on Listeria monocytogenes infection to Caco-2 cells and A/J mice. Anaerobe 18: 19-24.
71. Nase, L., K. Hatakka, E. Savilahti, M. Saxelin, A. Ponka, T. Poussa, R. Korpela and J.H. Meurman. 2001. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 35: 412-420.
72. Novick, R.P., H.F. Ross, S.J. Projan, J. Kornblum, B. Kreiswirth and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12: 3967-3975.
73. O’Connor, J.R., S. Johnson and D.N. Gerding. 2009. Clostridium diffi cile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136: 1913-1924.
74. Olano-Martin, E., M.R. Williams, G.R. Gibson and R.A. Rastall. 2003. Pectins and pecticoligosaccharides inhibit Escherichia coli O157:H7 Shiga toxin as directed towards the human colonic cell line HT29. FEMS Microbiol. Lett. 218: 101-105.
75. Parkes, G.C., J.D. Sanderson and K. Whelan. 2009. The mechanisms and effi cacy of probiotics in the prevention of Clostridium diffi cile-associated diarrhea. Lancet Infect. Dis. 9: 237-244.
76. Paton, A.W., R. Morona and J.C. Paton. 2006. Designer probiotics for prevention of enteric infections. Nat. Rev. Microbiol. 4: 193-200.
77. Paton, A.W., R. Morona and J.C. Paton. 2010. Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections. Bioeng. Bugs. 1: 172-177.
78. Peltonen, K., H. El-Nezami, C. Haskard, J. Ahokas and S. Salminen. 2001. Afl atoxin B1 binding by dairy strains of lactic acid bacteria and bifi dobacteria. J. Dairy Sci. 84: 2152-2156.
79. Petit, L., M. Gibert and M. R. Popoff. 1999. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 7: 104-110.
80. Reid, G. and A.W. Bruce. 2006. Probiotics to prevent urinary tract infections: the rationale and evidence. World J. Urol. 24: 28-32.
81. Reid, G., R.L. Cook and A.W. Bruce. 1987. Examination of strains of lactobacilli for properties that may infl uence bacterial interference in the urinary tract. J. Urol. 138: 330-335.
82. Ren, D., C. Li, Y. Qin, R. Yin, X. Li, M. Tian, S. Du, H. Guo, C. Liu, N. Zhu, D. Sun, Y. Li and N. Jin. 2012. Inhibition of Staphylococcus aureus adherence to Caco-2 cells by lactobacilli and cell surface properties that infl uence attachment. Anaerobe. 18: 508-515.
83. Reunanen, J., O. von, I, A.P. Hendrickx, A. Palva and W.M. de Vos. 2012. Characterization of the SpaCBA pilus fi bers in the probiotic Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 78: 2337-2344.
84. Sanchez, B. and M.C. Urdaci. 2012. Extracellular proteins from Lactobacillus plantarum BMCM12 prevent adhesion of enteropathogens to mucin. Curr. Microbiol. 64: 592-596.
85. Satish, K.R., P. Kanmani, N. Yuvaraj, K.A. Paari, V. Pattukumar and V. Arul. 2011. Lactobacillus plantarum AS1 binds to cultured human intestinal cell line HT-29 and inhibits cell attachment by enterovirulent bacterium Vibrio parahaemolyticus. Lett. Appl. Microbiol. 53: 481-487.
86. Songer, J.G. 1996. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 9: 216-234.
87. Spurbeck, R.R. and C.G. Arvidson. 2008. Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species. Infect. Immun. 76: 3124-3130.
88. Strom, K., J. Sjogren, A. Broberg and J. Schnurer. 2002. Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4- OH-L-Pro) and 3-phenyllactic acid. Appl. Environ. Microbiol. 68: 4322-4327.
89. Turpin, W., C. Humblot, M.L. Noordine, M. Thomas and J.P. Guyot. 2012. Lactobacillaceae and cell adhesion: genomic and functional screening. PLoS. One. 7: e38034.
90. Velraeds, M.M., B. Belt-Gritter, H.C. van der Mei, G. Reid and H.J. Busscher. 1998. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J. Med. Microbiol. 47: 1081-1085.
91. Vielfort, K., H. Sjolinder, S. Roos, H. Jonsson and H. Aro. 2008. Adherence of clinically isolated lactobacilli to human cervical cells in competition with Neisseria gonorrhoeae. Microbes. Infect. 10: 1325-1334.
92. Viscidi, R., S. Willey and J.G. Bartlett. 1981. Isolation rates and toxigenic potential of Clostridium diffi cile isolates from various patient populations. Gastroenterology 81: 5-9.
93. Watarai, S., Tana, K. Inoue, Y. Kushi, E. Isogai, K. Yokota, K. Naka, K. Oguma and H. Kodama. 2001. Inhibition of Vero cell cytotoxic activity in Escherichia coli O157:H7 lysates by globotriaosylceramide, Gb3, from bovine milk. Biosci. Biotechnol. Biochem. 65: 414-419.
94. Wine, E., M.G. Gareau, K. Johnson-Henry and P.M. Sherman. 2009. Strain-specifi c probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. FEMS Microbiol. Lett. 300: 146-152.
95. Wu, Q., A. Jezkova, Z. Yuan, L. Pavlikova, V. Dohnal and K. Kuca. 2009. Biological degradation of afl atoxins. Drug Metab. Rev. 41: 1-7.
96. Yarwood, J.M. and P.M. Schlievert. 2003. Quorum sensing in Staphylococcus infections. J. Clin. Invest. 112: 1620-1625.
97. Younes, J.A., H.C. van der Mei, E. van den Heuvel, H.J. Busscher and G. Reid. 2012. Adhesion forces and coaggregation between vaginal staphylococci and lactobacilli. PLoS. One. 7: e36917.
98. Yu, Q., L. Zhu, Z. Wang, P. Li and Q. Yang. 2012. Lactobacillus delbrueckii ssp. lactis R4 prevents Salmonella typhimurium SL1344-induced damage to tight junctions and adherens junctions. J. Microbiol. 50: 613-617.
99. Zeinhom, M., A.M. Tellez, V. Delcenserie, A.M. El-Kholy, S.H. El-Shinawy and M.W. Griffiths. 2012. Yogurt containing bioactive molecules produced by Lactobacillus acidophilus La-5 exerts a protective effect against enterohemorrhagic Escherichia coli in mice. J. Food Prot. 75: 1796-1805.